Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and butaclamol

arg-3-hyp-7-phe-bradykinin has been researched along with butaclamol in 3 studies

Compound Research Comparison

Studies
(arg-3-hyp-7-phe-bradykinin)
Trials
(arg-3-hyp-7-phe-bradykinin)
Recent Studies (post-2010)
(arg-3-hyp-7-phe-bradykinin)
Studies
(butaclamol)
Trials
(butaclamol)
Recent Studies (post-2010) (butaclamol)
522345016
52233308

Protein Interaction Comparison

ProteinTaxonomyarg-3-hyp-7-phe-bradykinin (IC50)butaclamol (IC50)
D(2) dopamine receptorHomo sapiens (human)0.0123
DRattus norvegicus (Norway rat)0.0053
D(3) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(1A) dopamine receptorHomo sapiens (human)0.05
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(4) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(3) dopamine receptorHomo sapiens (human)0.0139
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(4) dopamine receptorHomo sapiens (human)0.05
D(1B) dopamine receptorHomo sapiens (human)0.05
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0525

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E1
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1
Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L1

Other Studies

3 other study(ies) available for arg-3-hyp-7-phe-bradykinin and butaclamol

ArticleYear
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine

2016
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
    Bioorganic & medicinal chemistry, 2013, May-15, Volume: 21, Issue:10

    Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship

2013